Stroke, Vol 18, 1169-1172, Copyright © 1987 by American Heart Association
MI Chimowitz and MS Pessin
Proven effective therapy to prevent ischemic deficits and other
complications after subarachnoid hemorrhage is lacking despite extensive
research efforts. A literature review documented both clinical and
experimental evidence suggesting that heparin may be effective in
preventing ischemic deficits after subarachnoid hemorrhage by reversing
vasospasm, improving blood flow through narrowed vessels, and preventing
the development of a proliferative angiopathy. Additional evidence suggests
that heparinization of the cerebrospinal fluid following subarachnoid
hemorrhage may prevent the development of hydrocephalus. In the only
clinical trial using heparin after subarachnoid hemorrhage, the incidence
of rebleeding in the heparinized patients was no higher than in the control
group. We conclude that the existing preliminary data concerning a role for
heparin in the management of the complications of subarachnoid hemorrhage
is promising, but further controlled studies are needed prior to clinical
application.
ARTICLES
Is there a role for heparin in the management of complications of subarachnoid hemorrhage?
Department of Neurology, New England Medical Center, Boston, MA 02111.
This article has been cited by other articles:
![]() |
E. Busch, C. Beaulieu, A. de Crespigny, M. E. Moseley, and J. P. Muizelaar Diffusion MR Imaging During Acute Subarachnoid Hemorrhage in Rats • Editorial Comment Stroke, October 1, 1998; 29(10): 2155 - 2161. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |